USD 0.0
(0.0%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2022 | 33 Million USD | 11.01% |
2021 | 29.72 Million USD | 251.2% |
2020 | 8.46 Million USD | 126.48% |
2019 | 3.73 Million USD | 0.0% |
2018 | - USD | -100.0% |
2017 | 659.52 Thousand USD | 11.24% |
2016 | 592.86 Thousand USD | -2.56% |
2015 | 608.43 Thousand USD | -1.33% |
2014 | 616.63 Thousand USD | -6.5% |
2013 | 659.52 Thousand USD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 Q3 | - USD | 0.0% |
2023 Q2 | - USD | 0.0% |
2023 Q1 | - USD | -100.0% |
2022 Q3 | 30.01 Million USD | -1.78% |
2022 Q2 | 30.56 Million USD | 12.29% |
2022 FY | 33 Million USD | 11.01% |
2022 Q1 | 27.21 Million USD | -8.46% |
2022 Q4 | 33 Million USD | 9.95% |
2021 FY | 29.72 Million USD | 251.2% |
2021 Q1 | 18.74 Million USD | 121.43% |
2021 Q4 | 29.72 Million USD | 56.67% |
2021 Q2 | 17.63 Million USD | -5.91% |
2021 Q3 | 18.97 Million USD | 7.59% |
2020 FY | 8.46 Million USD | 126.48% |
2020 Q1 | - USD | 0.0% |
2020 Q4 | 8.46 Million USD | 0.0% |
2019 FY | 3.73 Million USD | 0.0% |
2019 Q4 | - USD | 0.0% |
2018 FY | - USD | -100.0% |
2018 Q4 | - USD | 0.0% |
2017 FY | 659.52 Thousand USD | 11.24% |
2017 Q4 | - USD | 0.0% |
2016 FY | 592.86 Thousand USD | -2.56% |
2015 Q2 | 636.26 Thousand USD | 0.0% |
2015 Q4 | 608.43 Thousand USD | 0.0% |
2015 Q1 | 636.26 Thousand USD | 3.18% |
2015 Q3 | 608.43 Thousand USD | -4.37% |
2015 FY | 608.43 Thousand USD | -1.33% |
2014 Q3 | 616.63 Thousand USD | 0.0% |
2014 Q4 | 616.63 Thousand USD | 0.0% |
2014 Q1 | - USD | 0.0% |
2014 FY | 616.63 Thousand USD | -6.5% |
2013 FY | 659.52 Thousand USD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
American Bio Medica Corporation | 6000.00 USD | -549916.65% |
Arrayit Corporation | - USD | -Infinity% |
Atlantic International Corp. | 1.29 Million USD | -2443.402% |
Biocept, Inc. | 10.37 Million USD | -218.082% |
Bioqual, Inc. | - USD | -Infinity% |
CardioGenics Holdings Inc | - USD | -Infinity% |
DermTech, Inc. | 51.3 Million USD | 35.681% |
Global WholeHealth Partners Corporation | - USD | -Infinity% |
Hangzhou Tigermed Consulting Co., Ltd. | 61.22 Million USD | 46.099% |
HTG Molecular Diagnostics, Inc. | 546.32 Thousand USD | -5940.555% |
iMD Companies, Inc. | 1.1 Million USD | -2890.126% |
IDenta Corp. | 428.17 Thousand USD | -7607.344% |
Interpace Biosciences, Inc. | 4.24 Million USD | -677.775% |
Integrative Health Technologies, Inc. | - USD | -Infinity% |
InVitro International | - USD | -Infinity% |
Lumos Diagnostics Holdings Limited | - USD | -Infinity% |
Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
Medical Imaging Corp. | 278 Thousand USD | -11770.863% |
NovelStem International Corp. | 3.32 Million USD | -892.631% |
Optigenex Inc. | 4.42 Million USD | -645.437% |
PharmChem, Inc. | - USD | -Infinity% |
Proteome Sciences plc | 1.63 Million USD | -1923.36% |
Response Genetics, Inc | 4.91 Million USD | -571.025% |
Rennova Health, Inc. | 359.19 Thousand USD | -9087.54% |
RushNet, Inc. | 4.25 Million USD | -676.058% |
ScreenPro Security Inc. | 249.05 Thousand USD | -13150.752% |
Stella Diagnostics Inc. | 798.44 Thousand USD | -4033.179% |
StageZero Life Sciences Ltd. | 576.38 Thousand USD | -5625.543% |